Latest UK News
The core focus of the webinar will be to provide an introduction to the APDP initiative and our newly appointed Director, Professor David Walsh. Participants will receive an overview of the Advanced Pain Discovery Platform (APDP) initiative, including its scientific scope, eligibility requirements, and the application process.
Scientists have long debated which genetic information carrier – DNA or RNA – started life on Earth, but a new study suggests life could have begun with a bit of both.
The Medical Research Council and Versus Arthritis and other Partners are pleased to announce the appointment of Professor David Walsh as Director for the UKRI Strategic Priorities Fund (SPF) Programme, Advanced Pain Discovery Platform (APDP).
The MRC in partnership with The Observer are proud to announce that the Max Perutz Science Writing Award 2020 is now open.
MRC-supported scientists are among the distinguished medical researchers elected as Fellows of the Academy of Medical Sciences.
A UK trial – testing whether low-risk treatment in the community can help people at higher risk of complications from COVID-19 to get better quicker, reducing the need for hospital admission – is today announcing that older people who have had coronavirus symptoms for 15 days or less can now also screen for the trial online.
A new call for research proposals on the risk factors, transmission and prevalence of the COVID-19 virus SARS-CoV-2, has been launch by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR).
A network of Gene Therapy Innovation Hubs providing access to clinical grade viral vector and translational support for early phase academic-led gene therapy clinical trials.
An international clinical trial, co-led by UKRI’s Medical Research Council and UCL, which is testing the effectiveness of the drug remdesivir on patients hospitalised with Covid-19, has shown “very promising” preliminary results.
To answer many urgent questions about the characteristics of people who are most severely affected by the virus and what happens to them in hospital, a study – called ‘ISARIC4C’ – has analysed data obtained from 16,749 COVID-19 hospital patients in the UK.
MRC-supported researchers are among the eminent scientists announced today, elected as Fellows of the Royal Society.
Coronavirus infections are a common cause of mild colds, infecting thousands of people every year in the UK. They mostly circulate in the winter in temperate regions where they are often referred to as ‘seasonal coronaviruses’.
Researchers at the University of Oxford have begun testing a COVID-19 vaccine in human volunteers this week. The phase I trial was funded by UKRI and NIHR as part of the rapid research response.
The NIHR and UKRI are jointly calling for research proposals to investigate emerging evidence of an association between ethnicity and COVID-19 incidence and adverse health outcomes.
COVID-19 therapy, vaccine, epidemiology and policy development research boosted by twenty-one new projects
Twenty-one new studies into the novel coronavirus have been funded by the UK government, including the first clinical drug trial in primary care, vaccine and therapy development, and studying epidemiology, disease transmission, behavioral interventions and policy approaches to COVID-19.
MRC is funding new research projects as part of the UK Research and Innovation response to the current COVID-19 pandemic through the DHSC/UKRI COVID-19 Rapid Response Initiative.
Given the current requirements for social distancing as a result of the Covid-19 pandemic, we are now exploring a virtual meeting / webinar on this date.
The MRC is pleased to announce that Professor KJ Patel has been appointed as the new Director of the MRC Molecular Haematology Unit and the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.
Six new studies into the novel coronavirus have been funded by the UK government, including testing a vaccine, developing therapies and improving understanding of how to treat COVID-19.
The Government and the UK’s Chief Scientific Adviser have today, Monday 23 March, backed the UK’s leading clinicians and scientists to map how COVID-19 spreads and behaves by using whole genome sequencing.